Literature DB >> 25359109

Mixed glioma with molecular features of composite oligodendroglioma and astrocytoma: a true "oligoastrocytoma"?

Jason T Huse1, Eli L Diamond, Lu Wang, Marc K Rosenblum.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25359109     DOI： 10.1007/s00401-014-1359-y

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  26 in total

1.  Outcome evaluation of patients with newly diagnosed anaplastic gliomas treated in a single institution.

Authors:  Federico Pessina; Pierina Navarria; Luca Cozzi; Stefano Tomatis; Elena Clerici; Anna Maria Ascolese; Matteo Simonelli; Matteo Perrino; Marco Riva; Marco Rossi; Roberta Rudà; Armando Santoro; Lorenzo Bello; Marta Scorsetti
Journal:  CNS Oncol       Date:  2017-07-18

2.  A Revised Diagnostic Classification of Canine Glioma: Towards Validation of the Canine Glioma Patient as a Naturally Occurring Preclinical Model for Human Glioma.

Authors:  Jennifer W Koehler; Andrew D Miller; C Ryan Miller; Brian Porter; Kenneth Aldape; Jessica Beck; Daniel Brat; Ingrid Cornax; Kara Corps; Chad Frank; Caterina Giannini; Craig Horbinski; Jason T Huse; M Gerard O'Sullivan; Daniel R Rissi; R Mark Simpson; Kevin Woolard; Joanna H Shih; Christina Mazcko; Mark R Gilbert; Amy K LeBlanc
Journal:  J Neuropathol Exp Neurol       Date:  2018-11-01       Impact factor: 3.685

3.  Concomitant 1p/19q co-deletion and IDH1/2, ATRX, and TP53 mutations within a single clone of "dual-genotype" IDH-mutant infiltrating gliomas.

Authors:  Cinthya J Zepeda-Mendoza; Rachael A Vaubel; Shabnam Zarei; Cristiane M Ida; Martin Matthews; Sara Acree; Aditya Raghunathan; Caterina Giannini; Robert B Jenkins
Journal:  Acta Neuropathol       Date:  2020-03-13       Impact factor: 17.088

Review 4.  Neuro-Oncology and Radiogenomics: Time to Integrate?

Authors:  A Lasocki; M A Rosenthal; S J Roberts-Thomson; A Neal; K J Drummond
Journal:  AJNR Am J Neuroradiol       Date:  2020-09-10       Impact factor: 3.825

Review 5.  Molecular Pathogenesis of Low-Grade Glioma.

Authors:  Devin Bready; Dimitris G Placantonakis
Journal:  Neurosurg Clin N Am       Date:  2019-01       Impact factor: 2.509

Review 6.  Advances in the molecular genetics of gliomas - implications for classification and therapy.

Authors:  Guido Reifenberger; Hans-Georg Wirsching; Christiane B Knobbe-Thomsen; Michael Weller
Journal:  Nat Rev Clin Oncol       Date:  2016-12-29       Impact factor: 66.675

7.  IDH mutation and 1p19q codeletion distinguish two radiological patterns of diffuse low-grade gliomas.

Authors:  Amélie Darlix; Jérémy Deverdun; Nicolas Menjot de Champfleur; Florence Castan; Sonia Zouaoui; Valérie Rigau; Michel Fabbro; Yordanka Yordanova; Emmanuelle Le Bars; Luc Bauchet; Catherine Gozé; Hugues Duffau
Journal:  J Neurooncol       Date:  2017-04-22       Impact factor: 4.130

8.  Oligodendrogliomas in pediatric and teenage patients only rarely exhibit molecular markers and patients have excellent survivals.

Authors:  Yan-Xi Li; Abudumijiti Aibaidula; Zhifeng Shi; Hong Chen; Kay Ka-Wai Li; Nellie Yuk-Fei Chung; Ryan Rui Yang; Danny Tat-Ming Chan; Wai Sang Poon; Ka Lok Ryan Lee; Ying Mao; Jinsong Wu; Aden Ka-Yin Chan; Liangfu Zhou; Ho-Keung Ng
Journal:  J Neurooncol       Date:  2018-05-14       Impact factor: 4.130

9.  Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomas.

Authors:  Josie Hayes; Yao Yu; Llewellyn E Jalbert; Tali Mazor; Lindsey E Jones; Matthew D Wood; Kyle M Walsh; Henrik Bengtsson; Chibo Hong; Stefan Oberndorfer; Thomas Roetzer; Ivan V Smirnov; Jennifer L Clarke; Manish K Aghi; Susan M Chang; Sarah J Nelson; Adelheid Woehrer; Joanna J Phillips; David A Solomon; Joseph F Costello
Journal:  Neuro Oncol       Date:  2018-04-09       Impact factor: 12.300

10.  Diagnostic revision of 206 adult gliomas (including 40 oligoastrocytomas) based on ATRX, IDH1/2 and 1p/19q status.

Authors:  Marta Mellai; Laura Annovazzi; Rebecca Senetta; Carmine Dell'Aglio; Marta Mazzucco; Paola Cassoni; Davide Schiffer
Journal:  J Neurooncol       Date:  2016-10-28       Impact factor: 4.506
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.